日日噜夜夜草|一级黄色录像高清版|调教白富美加勒比久久|亚洲欧洲精品婷婷|日韩综合无码色色|日韩精品一区妖精视频|亚洲无码中文字幕hd|99亚洲思思丝袜|手机看片国产精品大胆亚洲|成人无码视频一区二区在线播放

更新于 6月19日

on site QC manager

1.5-2.5萬(wàn)·13薪
  • 海口秀英區(qū)
  • 5-10年
  • 本科
  • 全職
  • 招1人

職位描述

生物藥生產(chǎn)管理QC質(zhì)量體系管理GMP認(rèn)證NMPA認(rèn)證
Major tasks & responsibilities:
Lead the analytical quality assurance for Sun Pharma Biologic product (Drug substance, Drug Product & combination product as required). Perform timely review in accordance with the MA and with the approved analytical method of QC analytical data originated at the testing site and timely preparation and issuance of CoAs as requried. Act as SME during evaluation and review of product related change controls, deviations, out of specifications, complaints and analytical method validations in regards to analytical testing of inprocess, intermediates and finished products. The QC Manager shall author scientifically sound deviation investigations and assessments and recommends effective corrective actions as appropriate. Maintain oversight and management of stability studies executed by the testing labs, including preparation/review of stability protocols, raw data and review/preparation of reports while ensuring proper follow up at the testing site of timely execution of testing plans as per scheduled time points. Liaise with external Analytical testing lab for ensuring testing of GMP analytical samples in accordance with approved specifications while maintaining as well oversight of on time testing and execution of stability sample testing. Creation, review and maintenance of testing analytical methods and specification ensuring compliance with validation studies and with the marketing authorizations while ensuring proper communication with the testing labs upon receipt or generation of change controls affecting approved analytical methods or relevant specifications. Preparation, review and assessment of routine trending of stability data collected for new and annual stability programs and ensuring immediate notification to the Senior QA Manager in case of observed trends or suspected out of specifications. Support/author analytical technical assessment as required for supporting deviation investigation or other relevant studies. Support the maintenance and update of quality management system related to analytical. Support the timely implementation of global and local standards and procedures in the Sun China unit by execution of associated GAPs assessments against localprocedures where required. Contribute to the interpretation of regulatory requirements in new or existing Biologics SOP′s. Support for the regulatory queries related to analytical topics Review & Approve the stability summary sheets. Approval of documents related to quality. Support technical,attendance & administrative requirement of team members. Key Performance Indicators/result areas On time preparation of CoA and on time batch release In time management and closure of significant quality events, change controls, complaints, deviations etc.) On time receipt and review of stability testing for each time point.Timely issuance of stability testing CoA. On time assessment and implementation of Global procedures into QA Biologic QMS. On time submission of approved stability studies to Regulatory authorities & others. Manage attendance management and other administrative requirement for team members. Education Qualifications (Graduate- Post Graduate) Mandatory ? BSc in Bio chemistry/biotechnology of pharmaceutical field. Preferred ? BSc. In biotechnology/biochemistry

工作地點(diǎn)

秀英區(qū)??谒幑壬镝t(yī)藥創(chuàng)新綜合體

職位發(fā)布者

郭女士/人事

昨日活躍
立即溝通
公司Logo盛發(fā)藥業(yè)(上海)有限公司
總公司印度太陽(yáng)藥業(yè)有限公司(Sunpharma)成立于1983年,是一家在印度股票市值排名第一的跨國(guó)制藥企業(yè),主要生產(chǎn)??扑幤芳捌湓纤帯N覀兊奶幏剿幹苿┲饕婕靶难?、中樞神經(jīng)、消化、呼吸等領(lǐng)域以及糖尿病等慢性疾病的治療。我們?cè)谒孀愕母鱾€(gè)治療領(lǐng)域均處于領(lǐng)先地位,銷售網(wǎng)絡(luò)覆蓋全球主要市場(chǎng),包括在美國(guó)、歐洲、東南亞、俄羅斯、中東、拉丁美洲、非洲及亞洲等重要的國(guó)際市場(chǎng),其中超過(guò)50%的銷售來(lái)自于歐美市場(chǎng)。2012和2014年,太陽(yáng)藥業(yè)被福布斯(Forbes Global)評(píng)選為全球百?gòu)?qiáng)最具創(chuàng)新力公司。盛發(fā)藥業(yè)(上海)有限公司是全資子公司,于2020年12月底成立,取代之前的代表處,更好的服務(wù)于中國(guó)市場(chǎng)。
公司主頁(yè)